Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2008
04/15/2008USRE40245 Gyrase inhibitors and uses thereof
04/15/2008US7358365 Process for the controlled increase in the molecular weight of polyethylenes
04/15/2008US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
04/15/2008US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases
04/15/2008US7358269 selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; pain
04/15/2008US7358268 Imidazole derivatives as factor Xa inhibitors
04/15/2008US7358263 Fused bicyclic-substituted amines as histamine-3 receptor ligands
04/15/2008US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
04/15/2008US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
04/15/2008US7358253 Indolylmaleimide derivatives
04/15/2008US7358251 Bcl-XL inhibitors; N-{[4-({(1R)-5-(dimethylamino)-1-[(phenylthio)methyl]pentyl}amino)-3-nitrophenyl]sulfonyl}-4-(4-fluorophenyl)piperidine-1-carboxamide; useful for promoting apoptosis; Anticancer agents; autoimmune diseases; antiinflammatory agents
04/15/2008US7358249 Heterocyclic compounds having inhibitory activity against HIV integrase
04/15/2008CA2411468C Thrombopoietin mimetics
04/10/2008WO2008043087A2 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
04/10/2008WO2008042925A1 Cyclic derivatives as modulators of chemokine receptor activity
04/10/2008WO2008042639A1 Compounds and compositions as protein kinase inhibitors
04/10/2008WO2008042282A2 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators
04/10/2008WO2008041075A1 Mglur5 modulators
04/10/2008WO2008040753A1 Indazolyl derivatives useful as potassium channel modulating agents
04/10/2008WO2008040649A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
04/10/2008WO2008040492A1 Substituted sulfonamide derivatives
04/10/2008WO2008027523A3 Salts of benzimidazolyl pyridyl ethers and formulations thereof
04/10/2008WO2008005569A3 Modulators of metabolism and the treatment of disorders related thereto
04/10/2008WO2007146115A3 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
04/10/2008WO2007143597A3 Organic compounds
04/10/2008WO2007136875A3 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
04/10/2008WO2007136640A3 Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
04/10/2008WO2007110868A3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
04/10/2008WO2007065662A3 Trisubstituted quinazolinone derivatives as vanilloid antagonists
04/10/2008WO2007003525A3 Cyclic anilino-pyridinotriazines as gsk-3 inhibitors
04/10/2008US20080086007 O-[2-(pyrazole-1-yl)pyridine-5-yl]methyl acetophenone oxime; reacting pyrazole in dimethylformamide, with O-(2-chloropyridine-5-yl)methyl acetonphenone oxime in presence of a base sodium hydride
04/10/2008US20080086005 Novel crystalline forms of aripiprazole
04/10/2008US20080086003 1-[4-amino-3,5-dibromo-N-[[4-(2,3,4,5-tetrahydro-2(1H)-oxo-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]-D-phenylalanyl]-4-(1-piperidinyl)-piperidine-p-toluenesulphonate or other inorganic organic salts; calcitonin gene related peptide-antagonist; useful for treating headache and migraine
04/10/2008US20080085921 Emesis, dyspepsia, gastroparesis, constipation, gastroesophageal reflux, or post-operative ileus; cisapride analogs; side effect reduction of adverse events; (R)-quinuclidin-3-yl 6-((3S,4R)-4-(4-amino-5-chloro-2-methoxybenzamido)-3-methoxypiperidin-1-yl)hexanoate or salts
04/10/2008US20080085910 For inflammatory bowel disease; oral administration, bioavailability, pharmacokinetics; 2-(2,6-Dichlorobenzamido)-5-[4-(ethyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid methyl ester for example
04/10/2008US20080085905 Pyrazine-2-carboxamide derivatives
04/10/2008US20080085904 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant
04/10/2008US20080085903 Novel crystalline forms of aripiprazole
04/10/2008US20080085901 Heteroaryl Substituted Quinolin-4-Ylamine Analogues
04/10/2008US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof
04/10/2008US20080085899 Tetrahydrothiopyrano pyrazole cannabinoid modulators
04/10/2008US20080085896 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
04/10/2008US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors
04/10/2008CA2667082A1 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
04/10/2008CA2665398A1 Indazolyl derivatives useful as potassium channel modulating agents
04/10/2008CA2665083A1 Mglur5 modulators
04/10/2008CA2664810A1 Substituted sulfonamide derivatives
04/10/2008CA2664621A1 Pyrazine-2-carboxamide derivatives
04/10/2008CA2663856A1 Jak-2 modulators and methods of use
04/09/2008EP1908762A2 Organic compounds
04/09/2008EP1908761A1 Organic compounds
04/09/2008EP1908752A1 Novel 2-quinolone derivative
04/09/2008EP1907860A2 Mass labels
04/09/2008EP1907385A2 Compounds
04/09/2008EP1907383A1 Gpcr agonists
04/09/2008EP1907382A1 Nitrocatechol derivatives as comt inhibitors
04/09/2008EP1907381A1 Antidiabetic oxazolidinediones and thiazolidinediones
04/09/2008EP1907376A2 Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders
04/09/2008EP1907375A2 Crystalline solvate of omeprazole sodium
04/09/2008EP1907374A2 Compounds
04/09/2008EP1907373A1 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
04/09/2008EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists
04/09/2008EP1907366A1 New imidazole derivatives, preparation method thereof and organic electronic device using the same
04/09/2008EP1907362A1 Amide derivatives as kinase inhibitors
04/09/2008EP1907361A1 Amide derivatives as kinase inhibitors
04/09/2008EP1906964A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists
04/09/2008EP1572651A4 Compounds useful as pesticides
04/09/2008EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials
04/09/2008EP0964864B1 Pyrido 2,3-d pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
04/09/2008EP0958287B2 Sulfamide-metalloprotease inhibitors
04/09/2008CN101160317A Process for preparing macrocyclic compounds
04/09/2008CN101160308A Methods of treating cancer and related methods
04/09/2008CN101160305A Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
04/09/2008CN101160304A Substituted aryl 1,4-pyrazine derivatives
04/09/2008CN101160303A 1-(2H)-isoquinolone derivative
04/09/2008CN101160287A 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
04/09/2008CN101160286A Process for the preparation of ccr-2 antagonist
04/09/2008CN101160128A Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
04/09/2008CN101157686A Method for selectively preparing (S)- rebeprazole by high enantiomer
04/09/2008CN101157685A Synthesis of 4-(piperidyl)(2-pyridyl)methanone-(e)-o-methyloxime and salts
04/09/2008CN101157684A Aspartic acid lomefloxacin hydrate and preparation and uses thereof
04/09/2008CN100379742C New tricyclic derivatives as LTD4 antagonists
04/09/2008CN100379727C Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
04/09/2008CN100379725C Immunoassay detection method for neonicotinyl insecticides
04/09/2008CN100379415C Hetero biaryl derivatives as matrix metalloproteinase inhibitors
04/08/2008US7355052 Melanocortin receptors; analgesivs; antiinflammatory agents; eating disorders; psycological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents
04/08/2008US7355051 Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
04/08/2008US7355047 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
04/08/2008US7355046 Chronic obstructive pulmonary dusease; asthma
04/08/2008US7355042 Sleep disorders; side effect reduction
04/08/2008US7354946 Biarylurea derivatives
04/08/2008US7354942 Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
04/08/2008US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
04/08/2008US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12
04/08/2008US7354939 Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
04/08/2008US7354938 4[2(2,4chlorophenyl)pyrazol]-phenyl-cyclopropan; 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor; antidiabrtic agent, obesity, insulin resistance; improved physicochemical (stability) and biological (activity to inhibit HSD1, specificity, bioavailability, metabolism)
04/08/2008US7354935 [18F][2-fluorodideuteromethoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]-([2S,3S]-2-phenyl-piperidin-3-yl)-amine; image of neurokinin-1 receptors using positron emission tomography; detection or quantification; bioassay; brain, tissues, inflammation where substance P is involved, Alzheimer's disease
04/08/2008US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease
04/08/2008US7354933 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
04/08/2008US7354932 Chemokine receptor binding heterocyclic compounds with enhanced efficacy